Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.83%

Gilead Sciences Inc. (GILD)

-NasdaqGS
103.53 Down 0.66(0.63%) Feb 27, 4:00PM EST
|After Hours : 103.48 Down 0.05 (0.05%) Feb 27, 7:58PM EST
Add to Portfolio
Prev Close:104.19
Open:104.28
Bid:N/A
Ask:104.95 x 200
1y Target Est:119.04
Beta:0.83
Earnings Date:Apr 20 - Apr 24 (Est.)
Day's Range:102.71 - 104.34
52wk Range:63.50 - 116.83
Volume:7,939,977
Avg Vol (3m):16,623,400
Market Cap:154.20B
P/E (ttm):14.09
EPS (ttm):7.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.63%154.20B
GSKDown 0.88%114.07B
PFEDown 0.78%216.24B
RHHBYUp 0.80%N/A

Key Statistics

Forward P/E (1 yr):9.99
P/S (ttm):6.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :9.53
Quarterly EPS Est (Mar-15) :2.26
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback